Medtronic PLC (BSP:MDTC34)
R$ 212.34 5.71 (2.76%) Market Cap: 565.80 Bil Enterprise Value: 652.53 Bil PE Ratio: 26.38 PB Ratio: 2.13 GF Score: 79/100

Medtronic PLC at Piper Sandler Healthcare Conference (Virtual) Transcript

Dec 02, 2020 / 03:30PM GMT
Release Date Price: R$295.05 (-0.50%)
Matthew Oliver O;Brien
Piper Sandler & Co., Research Division - MD & Senior Research Analyst

' -

All right. Good morning, everyone. Thank you so much for joining us during our annual health care conference, and I hope everything is going well with this virtual format. This is Matt O'Brien from Piper's equity research team. I'll be moderating this fireside chat with Medtronic. From the company is Mike Coyle, the Executive Vice President and President of the Cardiac and Vascular Group.

One quick housekeeping item. If you do have questions for Mike, there's a box at the bottom of the Zoom call here that you can send them in, and I'll ask on your behalf or you can e-mail me directly at [email protected].

So with that out of the way, let's go ahead and get started with the fireside. Mike, thanks so much for joining us this morning.

Michael J. Coyle
Medtronic plc - Executive VP and Group President of Cardiac & Vascular Group

Thanks for inviting me. Good to be here.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot